Suppr超能文献

人口健康推广时代初级保健就诊与结直肠癌筛查结果之间的关联

Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

作者信息

Halm Ethan A, Beaber Elisabeth F, McLerran Dale, Chubak Jessica, Corley Douglas A, Rutter Carolyn M, Doubeni Chyke A, Haas Jennifer S, Balasubramanian Bijal A

机构信息

Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

出版信息

J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.

Abstract

BACKGROUND

Population outreach strategies are increasingly used to improve colorectal cancer (CRC) screening. The influence of primary care on cancer screening in this context is unknown.

OBJECTIVE

To assess associations between primary care provider (PCP) visits and receipt of CRC screening and colonoscopy after a positive fecal immunochemical (FIT) or fecal occult blood test (FOBT).

DESIGN

Population-based cohort study.

PARTICIPANTS

A total of 968,072 patients ages 50-74 years who were not up to date with CRC screening in 2011 in four integrated healthcare systems (three with screening outreach programs using FIT kits) in the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium.

MEASURES

Demographic, clinical, PCP visit, and CRC screening data were obtained from electronic health records and administrative databases. We examined associations between PCP visits in 2011 and receipt of FIT/FOBT, screening colonoscopy, or flexible sigmoidoscopy (CRC screening) in 2012 and follow-up colonoscopy within 3 months of a positive FIT/FOBT in 2012. We used multivariable logistic regression and propensity score models to adjust for confounding.

RESULTS

Fifty-eight percent of eligible patients completed a CRC screening test in 2012, most by FIT. Those with a greater number of PCP visits had higher rates of CRC screening at all sites. Patients with ≥1 PCP visit had nearly twice the adjusted-odds of CRC screening (OR = 1.88, 95 % CI: 1.86-1.89). Overall, 79.6 % of patients with a positive FIT/FOBT completed colonoscopy within 3 months. Patients with ≥1 PCP visit had 30 % higher adjusted odds of completing colonoscopy after positive FIT/FOBT (OR = 1.30; 95 % CI: 1.22-1.40).

CONCLUSIONS

Patients with a greater number of PCP visits had higher rates of both incident CRC screening and colonoscopy after positive FIT/FOBT, even in health systems with active population health outreach programs. In this era of virtual care and population outreach, primary care visits remain an important mechanism for engaging patients in cancer screening.

摘要

背景

人群推广策略越来越多地用于改善结直肠癌(CRC)筛查。在这种情况下,初级保健对癌症筛查的影响尚不清楚。

目的

评估初级保健提供者(PCP)就诊与粪便免疫化学检测(FIT)或粪便潜血试验(FOBT)呈阳性后接受CRC筛查及结肠镜检查之间的关联。

设计

基于人群的队列研究。

参与者

基于人群的个性化方案优化筛查(PROSPR)联盟中四个综合医疗系统(三个使用FIT试剂盒进行筛查推广项目)中2011年未进行最新CRC筛查的968072名年龄在50 - 74岁的患者。

测量指标

从电子健康记录和管理数据库中获取人口统计学、临床、PCP就诊及CRC筛查数据。我们研究了2011年PCP就诊与2012年接受FIT/FOBT、筛查结肠镜检查或乙状结肠镜检查(CRC筛查)以及2012年FIT/FOBT呈阳性后3个月内进行后续结肠镜检查之间的关联。我们使用多变量逻辑回归和倾向评分模型来调整混杂因素。

结果

2012年58%的符合条件患者完成了CRC筛查测试,大多数是通过FIT。PCP就诊次数较多的患者在所有地点的CRC筛查率更高。有≥1次PCP就诊的患者CRC筛查的调整后比值几乎是两倍(OR = 1.88,95%CI:1.86 - 1.89)。总体而言,79.6%的FIT/FOBT呈阳性的患者在3个月内完成了结肠镜检查。有≥1次PCP就诊的患者在FIT/FOBT呈阳性后完成结肠镜检查的调整后比值高30%(OR = 1.30;95%CI:1.22 - 1.40)。

结论

即使在积极开展人群健康推广项目的医疗系统中,PCP就诊次数较多的患者在FIT/FOBT呈阳性后的首次CRC筛查率和结肠镜检查率也更高。在这个虚拟医疗和人群推广的时代,初级保健就诊仍然是促使患者参与癌症筛查的重要机制。

相似文献

1
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.
5
Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Cancer Med. 2019 Dec;8(17):7408-7418. doi: 10.1002/cam4.2604. Epub 2019 Oct 21.
7
Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
JAMA Netw Open. 2019 Aug 2;2(8):e1910305. doi: 10.1001/jamanetworkopen.2019.10305.
8
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.
9

引用本文的文献

1
Colorectal cancer screening in adults aged 45-49: provider availability, CT colonography access, and screening rates.
J Natl Cancer Cent. 2025 May 28;5(4):414-425. doi: 10.1016/j.jncc.2025.03.003. eCollection 2025 Aug.
2
It's a good idea, but are they willing? Assessing pharmacist willingness to deliver colorectal cancer screening.
Cancer Epidemiol Biomarkers Prev. 2025 Jul 30. doi: 10.1158/1055-9965.EPI-25-0275.
3
Socioeconomic disparity in stage at cancer diagnosis among patients with type 2 diabetes in Dutch primary care: a cross-sectional study.
BMJ Public Health. 2024 Mar 14;2(1):e000050. doi: 10.1136/bmjph-2023-000050. eCollection 2024 Jun.
4
Effect of GP visits in the compliance of preventive services: a cross-sectional study in Europe.
BMC Prim Care. 2024 May 15;25(1):165. doi: 10.1186/s12875-024-02400-w.
5
Improving Colorectal Cancer Screening in a Regional Safety-Net Health System over a 10-Year Period: Lessons for Population Health.
J Gen Intern Med. 2024 May;39(6):978-984. doi: 10.1007/s11606-023-08477-w. Epub 2023 Nov 6.
6
Availability of Primary Care Physicians and Racial Disparities in Colorectal Cancer-Related Mortality in the United States.
J Gastrointest Cancer. 2024 Mar;55(1):171-174. doi: 10.1007/s12029-023-00956-x. Epub 2023 Jul 7.
7
Patient preferences for the design of a pharmacy-based colorectal cancer screening program.
Cancer Causes Control. 2023 Dec;34(Suppl 1):99-112. doi: 10.1007/s10552-023-01687-x. Epub 2023 Apr 19.
8
Randomized controlled trials of biomarker targets.
Clin Trials. 2023 Feb;20(1):47-58. doi: 10.1177/17407745221131820. Epub 2022 Nov 14.
9
Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults.
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1701-1709. doi: 10.1158/1055-9965.EPI-21-1330.

本文引用的文献

1
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.
2
Population-based programs for increasing colorectal cancer screening in the United States.
CA Cancer J Clin. 2015 Nov-Dec;65(6):497-510. doi: 10.3322/caac.21295. Epub 2015 Sep 1.
3
Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data.
EGEMS (Wash DC). 2015 May 18;3(1):1171. doi: 10.13063/2327-9214.1171. eCollection 2015.
4
5
Development and validation of an algorithm for classifying colonoscopy indication.
Gastrointest Endosc. 2015 Mar;81(3):575-582.e4. doi: 10.1016/j.gie.2014.07.031. Epub 2015 Jan 8.
6
Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review.
Prev Med. 2015 Feb;71:40-8. doi: 10.1016/j.ypmed.2014.11.022. Epub 2014 Dec 4.
8
Low uptake of colorectal cancer screening among African Americans in an integrated Veterans Affairs health care network.
Gastrointest Endosc. 2014 Aug;80(2):291-8. doi: 10.1016/j.gie.2014.01.045. Epub 2014 Mar 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验